6Brust S, Duttmann H, Feldner J, et al. Shortening of the diagnostic window with a new combined HIV p24 antigen and an- ti-HIV-1/2/O screening test. J Virol Methods,2000,90:153-165.
10Maim K, yon Sydow M, Andersson S. Performance of three auto- mated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples. Transfus Med,2009,19:78-88.
6Sickinger E, Stieler M, Kaufman B, et al. Muhicenter of human immunode-ficiency virus-specific antib, odies and antigen [J]. J Clin Microbiol, 2004,42 ( 1 ) : 21-29.
7Speers D, Phillips P, Dyer J. Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window [J]. J Clin Microbiol, 2005,43(10) :5397-5399.
8Uneke C J, Alo M N, Ogbu O, et al. Western blot-indeterminate results in Nigerian patients HIV serodiagnosis: the clinical and public health implication [J]. AIDS Patient Care STDS, 2007,21 (3) : 169-176.
9Sudha T, Lakshmi V, Teja V D. Western blot profile in HIV infection [J]. Indian J Dermatol Venereol Leprol, 2006,72(5): 357-360.
10Grusky O, Roberts K J, Swanson A N. Communicating indeterminate HIV Western blot test results to clients: an observational study of three community testing sites [J]. AIDS Patient Care STDS, 2006, 20(9) :620-627.
8Bolivar F, Rodriguez RL, Greene PJ, et al. Construction and char- acterization of new cloning vehicles. II .A multipurpose cloning system[J]. Gene, 1977, 2:95-113.
9Vida! N, Mulanga C, Bazepeo SE, et al. Distribution of HIV -1 variants in the democratic republic of congo suggests increase of subtype C in kinshasa between 1997 and 2002 [J]. J Acquir Im- mune Defic Syndr, 2005, 40:456-462.
10Vidal N, Niyongabo T, Nduwimana J, et al. HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi [J]. AIDS Res Hum Retroviruses, 2007, 23:175-180.
